Name the topic
First line treatment
Comorbidities
SSRI safety and Tolerability
OCD Dosing
100

often underrecognized and underdiagnosed in youth, in part due to lack of patient lack of desire to seek help. First study in this topic ~20yrs ago

1-2% prevalence, genetic basis, PANDAS

Bimodal distribution in preadolescent children and young adults (mean age 21yo)

symptoms less pronounced later in life

Epidemiology

100

repeated exposure associated w decreased anxiety across graded exposure trials

Exposure/response prevention

Response prevention: provide adequate exposure and then blocking negative reinforcement effect of rituals or avoidance behavior, graded exposure

100

May cause difficulty treating patient

target OCD first → decrease anxiety contributing to symptoms

DMDD or other disruptive behavior disorders, ODD

100

especially in the setting of misuse or overdose, SSRIs safer and more well-tolerated than

TCAs

should come with an evaluation of the pediatric patient's medical condition and cardiac status, along with investigation of personal or family history of heart disease.

100

Preadolescent starting dose: 2.5-10mg

adolescent starting dose: 10-20mg

typical dose range (mean dose RCT): 10-80 (25mg)

Prozac

200

74% of youth w OCD meet criteria for at least one of these things; lower treatment response and remission w CBT

Those without have success rate over 70% w SSRI use

Comorbidities

May include DMDD, mood, eating, body dysmorphia, trichotillomania, nail biting, excoriation spectrum

Decrease in response with patients with comorbid ADHD (56%), tic disorder (53%), or oppositional defiant disorder (39%)

200

When possible, this the first line treatment for mild to moderate cases of OCD in children

Numerous studies have consistently shown its acceptability and efficacy  

CBT

200

important to identify before the initiation of an SSRI 

these pathologies may affect CBT treatment effectiveness and overall improvement for patients of all ages

Mood disorders

200

Increases of initial doses

every 3+ weeks

Takes 12 weeks for substantial benefits, yet may take 6 to 12 months for full effect

200

Preadolescent starting dose: 12.5-25mg

adolescent starting dose: 25-50mg

typical dose range (mean dose RCT): 50-200 (178mg)

Sertraline

300

Family studies shown OCD = genetic basis 

Monozygotic twin studies show higher rates of OCD than dizygotic twin studies

Higher risk of OCD in 1st0 family members, especially those w OCD in childhood

Glutamate receptor/modulating gene associated w dev of OCD

Pediatric Autoimmune Neuropsychiatric Disorders (PANDAS): an immune response to group A β-hemolytic streptococcus (GABHS) infections, causing a cross reactivity with, and inflammation of basal ganglia, w distinct neurobehavioral syndrome

Includes Sydenham chorea, a consequence of rheumatic fever; includes OCD, tics, and hyperactivity

Etiology 

300

Although Medications for OCD in child and adolescent patients began with clomipramine in 1989, Subsequent trials gained approval for this type of medication

SSRIs

300

less common in children w OCD, may become more frequent during adolescence

medical considerations must be stabilized prior to mental health interventions

eating disorders

300

medication can be gradually withdrawn over several months at this point, however

After 2-3 relapses of at least moderate severity, consider longer-term treatment

After stabilization for 6 to 12 months

300

Preadolescent starting dose: 12.5-25mg

adolescent starting dose: 25-50mg

typical dose range (mean dose RCT): 50-300 (165mg)

Fluvoxamine

400

Children's Yale-Brown Obsessive-Compulsive Scale (CY-BOCS) - use "worst-report algorithm" to be most accurate - combine positive findings from interview and scale

others - Leyton Obsessional Inventory; Ten Year Review of Rating Scales II for Internalizing Disorders; anxiety - Anxiety Disorders Interview Schedule for Children, Pediatric Anxiety Rating Scale, the Screen for Child Anxiety Related Disorders, and Multidimensional Anxiety Scale for Children

Symptom Rating Scale

400

2004 Study with Participants that were randomly assigned to receive CBT alone, sertraline alone, combined CBT and sertraline, or pill placebo for 12 weeks. 

CBT alone did not differ statistically from sertraline alone initially, was superior for the remission rate 

CBT and sertraline combination were better than placebo

Long-term studies on Sertraline suggested a cumulative benefit with gradually decreasing scalar scores and increasing remission rates for up to one year

Pediatric OCD Treatment Study (POTS) randomized controlled trial

400

Usually NOT preceded by specific cognitions (obsessions) - more like a sense of tension that is general or localized

Behavior is often a source of (temporary) gratification but may be followed by remorse and shame and mainstay of treatment is Behavioral therapy not SSRIs

“spectrum” of compulsive/impulsive habit disorders include trichotillomania, compulsive nail biting, skin picking, and other forms of self-injury

400

Increased risk of increased suicidal behavior remains a concern;

Should be noted that no suicides occurred in any of the pediatric randomized controlled trials of SSRIs.

Black Box Warning

400

Preadolescent starting dose: 2.5-10mg

adolescent starting dose: 10-20mg

typical dose range (mean dose RCT): 10-60

Citalopram

500

Symptoms can progress over childhood with developmental themes that may distinguish them from adults 

In young children, often unable to verbalize symptoms and compulsions may be exhibited without clear obsessions and/or rituals other than typical washing, repeating ordering, counting or checking

Majority will have many obsessions and compulsions over lifetime

No consistency with nature, age, or gender, but often revolve around catastrophic family event like death of caretake

M>F ratio occurrence in younger ages; usual onset age 7-13 

Clinical presentation/phenotype

500

do NOT seem to directly alter OCD symptoms, BUT rather help to encourage exposure and so produce an indirect, clinical benefit

Positive reinforcements, Rewards

Punishment is unhelpful

500

usually starts in adolescence, but possibly sooner, when developmental pressure increases regarding appearance

Body dysmorphic disorder

500

Whereas behavioral side effects are more common in younger children, such as behavioral activation, Peripubertal children exposed to antidepressants are at higher risk of ____?

Conversion to mania

500

Preadolescent starting dose: 6.25-25mg

adolescent starting dose: 25mg

typical dose range (mean dose RCT): 50-200mg

Clomipramine

M
e
n
u